See more : Van de Velde NV (VAN.BR) Income Statement Analysis – Financial Results
Complete financial analysis of Minerva Surgical, Inc. (UTRS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Minerva Surgical, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Sydinvest Tyskland KL (SYITYSKADKK.CO) Income Statement Analysis – Financial Results
- Warriedar Resources Limited (WA8.AX) Income Statement Analysis – Financial Results
- Prodware (ALPRO.PA) Income Statement Analysis – Financial Results
- SALA Corporation (2734.T) Income Statement Analysis – Financial Results
- Jayud Global Logistics Limited (JYD) Income Statement Analysis – Financial Results
Minerva Surgical, Inc. (UTRS)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://minervasurgical.com
About Minerva Surgical, Inc.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 50.29M | 52.10M | 37.77M | 26.01M |
| Cost of Revenue | 23.05M | 21.58M | 18.65M | 14.21M |
| Gross Profit | 27.24M | 30.52M | 19.12M | 11.81M |
| Gross Profit Ratio | 54.17% | 58.58% | 50.62% | 45.38% |
| Research & Development | 5.44M | 5.29M | 3.32M | 935.00K |
| General & Administrative | 14.37M | 22.18M | 8.21M | 8.38M |
| Selling & Marketing | 38.33M | 32.19M | 22.97M | 22.13M |
| SG&A | 52.70M | 54.38M | 31.19M | 30.51M |
| Other Expenses | 0.00 | -340.00K | 71.00K | 171.00K |
| Operating Expenses | 58.14M | 59.67M | 34.51M | 31.44M |
| Cost & Expenses | 81.19M | 81.25M | 53.16M | 45.65M |
| Interest Income | 89.00K | 10.00K | 81.00K | 135.00K |
| Interest Expense | 3.22M | 11.73M | 12.14M | 17.58M |
| Depreciation & Amortization | 10.81M | 10.29M | 7.23M | 1.98M |
| EBITDA | -20.07M | -18.86M | -8.16M | -17.66M |
| EBITDA Ratio | -39.91% | -36.19% | -21.61% | -67.88% |
| Operating Income | -30.90M | -29.15M | -15.39M | -19.64M |
| Operating Income Ratio | -61.44% | -55.94% | -40.75% | -75.49% |
| Total Other Income/Expenses | -3.20M | 7.69M | -3.01M | -32.41M |
| Income Before Tax | -34.10M | -21.46M | -18.40M | -52.05M |
| Income Before Tax Ratio | -67.80% | -41.18% | -48.71% | -200.08% |
| Income Tax Expense | 11.00K | 9.00K | -132.00K | 17.75M |
| Net Income | -34.11M | -21.46M | -18.26M | -69.80M |
| Net Income Ratio | -67.83% | -41.20% | -48.36% | -268.32% |
| EPS | -23.68 | -61.22 | -17.91 | -75.29 |
| EPS Diluted | -23.68 | -61.22 | -17.91 | -75.29 |
| Weighted Avg Shares Out | 1.44M | 350.61K | 1.02M | 927.03K |
| Weighted Avg Shares Out (Dil) | 1.44M | 350.61K | 1.02M | 927.03K |
Minerva Surgical, Inc. (UTRS) CEO David Clapper on Q1 2022 Results - Earnings Call Transcript
Minerva Surgical to Present at Upcoming Investor Conferences
Minerva Surgical to Announce Fourth Quarter and Full-Year Financial Results
Minerva Surgical to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Minerva Surgical's Preliminary FY21 Revenues Top Expectations
Minerva Surgical to Present at the 40th Annual J.P. Morgan Healthcare Conference
Minerva Surgical - Uterine Play For Sale
Source: https://incomestatements.info
Category: Stock Reports